The Utility of a Resting Electrocardiogram (ECG-PH Index) in Evaluating the Efficacy of Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension

被引:0
|
作者
Pilka, Michal [1 ]
Darocha, Szymon [1 ]
Florczyk, Michal [1 ]
Manczak, Rafal [1 ]
Banaszkiewicz, Marta [1 ]
Kedzierski, Piotr [1 ]
Zielinski, Dariusz [2 ,3 ]
Wrobel, Krzysztof [2 ,3 ]
Torbicki, Adam [1 ]
Kurzyna, Marcin [1 ]
机构
[1] European Hlth Ctr, Ctr Postgrad Med Educ, Chair & Dept Pulm Circulati Thromboembol Dis & Car, PL-05400 Otwock, Poland
[2] Medicover Hosp, Cardiac Surg Dept, PL-02972 Warsaw, Poland
[3] Lazarski Univ, Fac Med, PL-02662 Warsaw, Poland
关键词
electrocardiography; pulmonary hypertension; chronic thromboembolic pulmonary hypertension; pulmonary endarterectomy; DIAGNOSIS; ANGIOPLASTY; EXPERIENCE; OVERLOAD;
D O I
10.3390/jcm12247621
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The ECG-PH index (PH-ECG score) has been proposed as a valuable ECG-derived method of evaluating the effectiveness of balloon pulmonary angioplasty (BPA) in chronic thromboembolic pulmonary hypertension (CTEPH). Pulmonary endarterectomy (PEA) is the main form of therapy for CTEPH with a proximal clot location. The objective of this study was to assess the clinical utility of a resting electrocardiogram (ECG-PH index) in assessing the effectiveness of PEA in CTEPH patients. Methods: The retrospective analysis included 73 patients who underwent PEA. Their ECG-PH index values were calculated using four ECG parameters: R-wave amplitude V-1 + S-wave amplitude V-5/V-6 > 10.5 mm, QRS-wave axis > 110 degrees, R-wave amplitude V-1 > S-wave amplitude V-1, and SIQIII pattern. PH-ECG scores were assessed after a median time of 13 months (IQR: 8-31 months) had passed since the PEA procedures. Results: The current analysis documented that ECG-PH index = 0 is a good reflection of mPAP < 25mmHg (sensitivity 76.1%; specificity 66.7%; positive predictive value 79.5%; negative predictive value 62.1%) or mPAP <= 20 mmHg (sensitivity 69.6%; specificity 70.6%; positive predictive value 88.6%; negative predictive value 41.4%) after PEA. The values of the area under the ROC curve for ECG-PH index were 0.772 (95% CI: 0.676-0.867) and 0.743 (95% CI: 0.637-0.849) for the mPAP < 25 mmHg and mPAP <= 20 mmHg patient groups, respectively. Conclusion: The ECG-PH index may be useful for monitoring the haemodynamic effect of PEA in CTEPH patients.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] NATIONWIDE TRENDS IN PULMONARY ARTERY ENDARTERECTOMY FOR CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
    Kanmanthareddy, Arun
    Aggarwal, Saurabh
    Saurav, Alok
    Koduri, Hemantha
    Pandya, Jitendra
    Akinapelli, Abhilash
    Azzouz, Muhammad Soubhi
    White, Michael
    Kaushik, Manu
    Esterbrooks, Dennis
    Del Core, Michael
    Hunter, Claire
    Mooss, Aryan
    Alla, Venkata
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 2044 - 2044
  • [32] Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension
    Kallonen, Janica
    Korsholm, Kasper
    Bredin, Fredrik
    Corbascio, Matthias
    Jonsson Andersen, Mads
    Ilkjaer, Lars Bo
    Mellemkjaer, Soren
    Sartipy, Ulrik
    PULMONARY CIRCULATION, 2022, 12 (02)
  • [33] PULMONARY ENDARTERECTOMY FOR CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION IN A PATIENT WITHOUT DVT
    Dawood, Z.
    Chauhan, S.
    Kamran, S.
    Pervez, M.
    Fatimi, S.
    CHEST, 2020, 157 (06) : 407A - 407A
  • [34] Clinical worsening after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension
    Scholzel, B.
    Snijder, R.
    Morshuis, W.
    Saouti, N.
    Plokker, T.
    Post, M.
    NETHERLANDS HEART JOURNAL, 2011, 19 (12) : 498 - 503
  • [35] Outcome after Pulmonary Endarterectomy for Segmental Chronic Thromboembolic Pulmonary Hypertension
    de Perrot, M.
    McRae, K.
    Donahoe, L.
    McInnis, M.
    Thenganatt, J.
    Bykova, A.
    Tan, K.
    Moric, J.
    Mak, S.
    Granton, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S130 - S130
  • [36] Outcomes of Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension Patients in Latvia
    Skride, Andris
    Rudzitis, Ainars
    Kalejs, Martins
    Lesina, Krista
    CARDIOLOGY, 2015, 131 : 19 - 19
  • [37] Time trends of pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension
    Hobohm, L.
    Keller, K.
    Munzel, T.
    Konstantinides, S., V
    Lankeit, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2265 - 2265
  • [38] Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: preliminary exploration in China
    Gu Song
    Liu Yan
    Su Pi-xiong
    Zhai Zhen-guo
    Yang Yuan-hua
    Wang Chen
    CHINESE MEDICAL JOURNAL, 2010, 123 (08) : 979 - 983
  • [39] Evaluating the efficacy and safety of rivaroxaban as a warfarin alternative in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy: A randomized clinical trial
    Barati, Saghar
    Amini, Hossein
    Ahmadi, Zargham Hossein
    Dastan, Alireza
    Kashani, Babak Sharif
    Eskandari, Raha
    Dastan, Farzaneh
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2023, 42 (02) : 139 - 144
  • [40] Pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: The Singapore experience
    Ruan, Wen
    Yap, Jonathan
    Quah, Kevin
    Cheah, Foong Koon
    Phua, Ghee Chee
    Sewa, Duu Wen
    Ismail, Aidila Binte
    Chia, Alicia
    Jenkins, David
    Le Tan, Ju
    Chao, Victor
    Lim, Soo Teik
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2021, 50 (03) : 270 - 273